Effect of plasma homocysteine concentration on early and late events in patients with acute coronary syndromes

Circulation

Volumn 102, Issue 6, 2000, Pages 605-610

  Stubbs, Peter J ^a   Al Obaidi, Mohamed K ^b   Conroy, Ronan M ^d   Collinson, Paul O ^c   Graham, Ian M ^d   Noble, Mark I M ^b  

^a WATFORD GENERAL HOSPITAL   (United Kingdom)

^b CHARING CROSS HOSPITAL   (United Kingdom)

^c ST GEORGE S HOSPITAL   (United Kingdom)

^d ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

Coronary disease; Homocysteine

Indexed keywords

HOMOCYSTEINE;

ADULT; AGED; ARTICLE; FEMALE; HEART DEATH; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HOMOCYSTINURIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; UNSTABLE ANGINA PECTORIS;

EID: 0034622608     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.102.6.605     Document Type: Article

References (37)

1. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: Probable benefits of increasing folic acid intakes
2. Plasma homocysteine as a risk factor for vascular disease: The European Concerted Action Project
3. Vascular pathology of homocystinemia: Implications for the pathogenesis of arteriosclerosis
4. The natural history of homocystinuria due to cystathionine β-synthase deficiency
5. Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine
6. Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells
7. Acute methionine load-induced hyperhomocysteinemia enhances platelet aggregation, thromboxane biosynthesis, and macrophage-derived tissue factor activity in rats
8. Relationships between homocysteine, factor VIIa, and thrombin generation in acute coronary syndromes
9. Endothelial cell injury due to copper catalyzed hydrogen peroxide generation from homocysteine
10. Human arterial endothelial cell detachment in vitro: Its promotion by homocysteine and cysteine
11. A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to reduce events)
12. International diagnostic criteria for acute myocardial infarction and acute stroke
13. Fully automated fluorescence assay for determining total homocysteine in plasma
14. Homocysteine and other thiols in plasma and urine: Automated determination and sample stability
15. Troponin T for the differential diagnosis of ischaemic myocardial damage
16. Cox regression analysis of multivariate failure time data: The marginal approach
17. Graphical assessment of the Cox proportional hazards assumption
18. Plasma homocysteine levels and mortality in patients with coronary artery disease
19. Serum total homocysteine and coronary heart disease
20. Hyperhomocysteinemia: An independent risk factor for vascular disease
21. Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease
22. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians
23. Homocyst(e)ine and risk of cardiovascular disease in the Multiple Risk Factor Intervention Trial
24. Homocystinuria: Pathogenetic mechanisms
25. Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans
26. An atherogenic stimulus homocysteine inhibits cofactor activity of thrombomodulin and enhances thrombomodulin expression in human umbilical vein endothelial cells
27. Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism
28. Folic acid: An innocuous means of reducing plasma homocysteine
29. Lowering blood homocysteine with folic acid based supplements: Meta-analysis of randomised trials
30. 6, pyridoxal phosphate, and folate
31. Plasma homocysteine in acute myocardial infarction: Homocysteine-lowering effect of folic acid
32. Reduction of plasma homocysteine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease
33. 6 and folate reduce homocysteine concentration in coronary artery disease
34. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population
35. Vitamin intake: A possible determinant of plasma homocyst(e)ine among middle-aged adults
36. The natural history of vascular disease in homocystinuria and the effects of treatment